TruBridge (TBRG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Filed 10-K after identifying non-cash, non-material out-of-period adjustments related to revenue recognition, capitalized software, and non-routine transactions, reflecting improved financial controls.
Engaged in a strategic review process to maximize shareholder value, considering options such as sale, joint venture, share repurchases, or organic investments; no formal guidance issued.
Strong pipeline growth, with recurring deals now over 70% of opportunities and recurring revenue comprising 94% of total revenue for both the quarter and year.
Operational improvements include global workforce transition, new leadership, offshoring strategy, and AI-driven initiatives across financial health, patient care, and customer service.
Bookings for Q4 were $19.8 million, up from $14.3 million year-over-year; full-year bookings $82.9 million, up slightly from $82.1 million.
Financial highlights
Q4 revenue was $87.2 million, flat with guidance; Adjusted EBITDA $19.2 million (22% margin), at high end of range, up from $17.9 million.
Full-year revenue reached $346.8 million, up 1.4% year-over-year; Adjusted EBITDA $68.7 million (19.8% margin), up from $55.9 million.
Q4 GAAP net loss was $5.5 million, compared to a $5.1 million loss in the prior year; full-year GAAP net income was $4.4 million versus a $20.9 million loss.
Q4 Non-GAAP net income was $11.4 million, up from $1.1 million; full-year Non-GAAP net income was $38.5 million, up from $4.6 million.
Cash and cash equivalents increased to $24.9 million at year-end from $12.3 million; net debt reduced to $139.8 million.
Outlook and guidance
No formal guidance due to ongoing strategic review and difficulty forecasting certain expenses, but anticipate modest revenue growth and ~200 basis points Adjusted EBITDA margin expansion in 2026.
Focus for 2026 includes targeted AI initiatives, technology modernization, and continued operational improvements.
Margin expansion expected from global workforce transition, cost optimization, and improved revenue mix.
Latest events from TruBridge
- RCM gains and margin expansion offset EHR declines as full-year guidance is reaffirmed.TBRG
Q2 20242 Feb 2026 - RCM growth, offshoring, and analytics drive TruBridge's margin and operational focus.TBRG
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Revenue and bookings rose, but net loss widened and internal control weaknesses persisted.TBRG
Q3 202415 Jan 2026 - Recurring revenue, offshoring, and automation drive growth and margin expansion into 2025.TBRG
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Margin gains, SaaS shift, and RCM growth drive a strong outlook in rural healthcare.TBRG
KeyBanc Annual Healthcare Forum 202526 Dec 2025 - 2024 revenue $339.2M, EBITDA up, leverage down, 2025 margin and revenue growth expected.TBRG
Q4 202424 Dec 2025 - Key proposals include board declassification, incentive plan expansion, and strong 2024 results.TBRG
Proxy Filing1 Dec 2025 - Shareholders will vote on board declassification, incentive plan expansion, and executive pay.TBRG
Proxy Filing1 Dec 2025 - Key votes include board declassification, director elections, and incentive plan expansion.TBRG
Proxy Filing1 Dec 2025